Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02768792
Title High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins School of Medicine The Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21205 United States Details
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 United States Details
*Shaded cells indicate that there was no data available from for the field